DayOne Accelerator

MODERATE Tx General

Strategy Notes

The DayOne Accelerator is a strong fit for the venture's pharma R&D focus, offering no-equity support and access to major pharma players in Basel. However, the 2026 call is closed and the 2027 deadline is not specified, so timing may be a challenge. The venture's AI-driven drug resistance prediction aligns well with the program's emphasis on techbio tools for pharma.

Key Materials

—

Your Notes

Status & Deadline

Status: HUMAN_REQUIRED
Deadline: —
Cycle: rolling
Amount: —
Type: accelerator
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-08-03 OPEN → HUMAN_REQUIRED · The 2026 call is closed. The applicant must manually fill out the 'Express interest for 2027' form (linked on the page) to be notified when the 2027 application opens. This cannot be automated because the form is a standalone Microsoft Dynamics form and the 2027 application details are not yet available.